Collegium Pharmaceutical Inc expected to post earnings of $1.04 a share - Earnings Preview

Collegium Pharmaceutical

23/02/2022 03:04

* Collegium Pharmaceutical Inc  COLL.OQ   COLL.O  is
expected
to show a rise in quarterly revenue when it reports  results on
February 24. 
    * The Stoughton Massachusetts-based  company is expected to
report
 a 7.0% increase in revenue to $81.607 million from $76.27
million a year ago, according to the mean estimate from 7
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Collegium
Pharmaceutical
Inc is for earnings of $1.04 per share. For the same quarter
last year, the company reported earnings of 20 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and 1 "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Collegium
Pharmaceutical Inc is $27.5​, about 19.4% above​ its last
closing price of $22.17. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2021  0.95        0.95       0.22      Missed  -76.9
 Jun. 30 2021  0.36        0.47       0.27      Missed  -42.8
 Mar. 31 2021  0.30        0.42       0.41      Missed  -2.8​
 Dec. 31 2020  0.28        0.39       0.20      Missed  -48.5
 ​​Sep.        0.23        0.41       0.32      Missed  -21.7
 30 2020                                                
 Jun. 30 2020  0.18        0.31       0.23      Missed  -24.6​
 Mar. 31 2020  0.39        0.41       0.01      Missed  -97.6
 Dec. 31 2019  -0.03       -0.09      -0.07     Beat    18.3
 This summary was machine generated February 23 at 03:04 GMT. 
All figures in US dollars  unless otherwise stated